Announcement on Abnormal Fluctuations in Stock Trading
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
Announcement on Abnormal Fluctuations in Stock Trading
Filed with SSE ·
6ix hasn’t read this filing yet.
Shanghai Shen Lian Biomedical Corporation on 6ix
Earlier from Shanghai Shen Lian Biomedical
- Announcement on the Signing of a Cooperative Development Agreement for Multivalent Vaccine Projects with Lanzhou Veterinary Research Institute of the Chinese Academy of Agricultural Sciences
- Announcement on Voluntary Disclosure of Registration Approval for New Veterinary Drug Products
- Announcement on Voluntary Disclosure of Approval Numbers for Approved Veterinary Drug Products
- Announcement on Implementation Results of Share Repurchase and Share Changes
- Announcement on Resolution of the 2024 Annual General Meeting
Later from Shanghai Shen Lian Biomedical
- Special Report on Deposit and Use of Raised Funds in January-June 2025
- Announcement on Voluntary Disclosure of the Progress in Phase II Clinical Trial for Innovative Drug UB-221 of the Joint-Stock Company
- Announcement on Attending the 2025 Semi-annual SSE STAR Market Innovative Drug Industry Collective Performance Briefing
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
- Announcement on Shareholding Reduction Plan for Shareholders with Over 5% Shares
Follow Shanghai Shen Lian Biomedical into a list and get an email when it puts out news.
Follow Shanghai Shen Lian Biomedical